Since the start of mass COVID-19 vaccination campaigns, millions of people around the world have received doses that helped slow the pandemic and drastically reduce severe cases and deaths.

However, over time, reports of rare side effects began to surface — among them, one that caught the medical community’s attention: myocarditis, an inflammation of the heart muscle.

What Is Myocarditis?

Myocarditis is a condition where the heart tissue becomes inflamed, which can affect its ability to pump blood efficiently. In most cases, it’s mild and resolves with medical treatment, though some patients may need to be monitored in a hospital.

Scientific studies have shown that this side effect occurs more often in young men, particularly those under 30, and usually appears a few days after receiving the second dose of an mRNA vaccine such as Pfizer-BioNTech or Moderna.

Recognizing the Symptoms

The most common symptoms linked to this reaction include chest pain, shortness of breath, heart palpitations, or unusual fatigue. Experts emphasize that anyone experiencing these symptoms should seek immediate medical attention, as early diagnosis greatly improves recovery time and safety.

How Common Is It?

Health organizations, including the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC), have confirmed that myocarditis cases related to vaccines are extremely rare compared to the vast number of doses administered. They also stress that the benefits of vaccination—preventing hospitalization and death from COVID-19—far outweigh any potential risks.